Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants
- PMID: 8375112
- DOI: 10.1007/BF00132980
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants
Abstract
The structure and the function of the p53 gene were studied in two metastatic cell variants derived from Lewis lung carcinoma. Single missense mutation at codon 334 was detected in the p53 gene of both cell variants. In spite of the identical mutation, the in vitro and in vivo growth rates of the two cell variants were differentially affected by the constitutive expression of exogenous wild-type (wt) p53 gene. In fact, only the more malignant cell line (C87) was severely affected by the wt-p53 gene introduction. However, the in vivo effects on this cell line were transient because during serial in vivo passages, cell populations lacking the wt-p53 gene were selected. Genetic mechanisms responsible for the resistance of the less metastatic cell variant (BC215) to the wt-p53 expression, were investigated. Intrinsic ability to mutate exogenous cDNA sequences was tested. We report that BC215 cells continued to express exogenous wt-p53 sequences after several in vitro passages. The expression of mdm2 gene was evaluated. The data demonstrated that BC215 cells constitutively express higher levels of mdm2 gene than C87 cells. We conclude that the overexpression of this gene might be responsible for the resistance of BC215 cells to exogenous wt-p53 gene expression.
Similar articles
-
Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein.Cancer Res. 1992 Dec 15;52(24):6956-60. Cancer Res. 1992. PMID: 1458487
-
Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.Br J Cancer. 1998 Jun;77(12):2215-22. doi: 10.1038/bjc.1998.369. Br J Cancer. 1998. PMID: 9649136 Free PMC article.
-
[Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].Zhonghua Jie He He Hu Xi Za Zhi. 1998 May;21(5):268-72. Zhonghua Jie He He Hu Xi Za Zhi. 1998. PMID: 11326947 Chinese.
-
Alterations of the p53 tumor suppressor gene during mouse skin tumor progression.Cancer Res. 1991 Dec 15;51(24):6615-21. Cancer Res. 1991. PMID: 1742735
-
P53-mediated radioresistance does not correlate with metastatic potential in tumorigenic rat embryo cell lines following oncogene transfection.Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):341-55. doi: 10.1016/0360-3016(95)02023-3. Int J Radiat Oncol Biol Phys. 1996. PMID: 8567335 Review.
Cited by
-
Retinoic acid negatively regulates beta 4 integrin expression and suppresses the malignant phenotype in a Lewis lung carcinoma cell line.Clin Exp Metastasis. 1994 Jan;12(1):63-72. doi: 10.1007/BF01784335. Clin Exp Metastasis. 1994. PMID: 8287622
-
Precise tumor immune rewiring via synthetic CRISPRa circuits gated by concurrent gain/loss of transcription factors.Nat Commun. 2022 Mar 18;13(1):1454. doi: 10.1038/s41467-022-29120-y. Nat Commun. 2022. PMID: 35304449 Free PMC article.
-
Targeting p53-dependent stem cell loss for intestinal chemoprotection.Sci Transl Med. 2018 Feb 7;10(427):eaam7610. doi: 10.1126/scitranslmed.aam7610. Sci Transl Med. 2018. PMID: 29437148 Free PMC article.
-
The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®.EJNMMI Res. 2014 Jan 4;4(1):2. doi: 10.1186/2191-219X-4-2. EJNMMI Res. 2014. PMID: 24387284 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous